Hedge Fund - Euclidean Capital

Rapt Therapeutics Inc. (RAPT) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2023 - Q4 (2023-12-31) $16,348,790 1.83% 657,899 $15.47
2 2023 - Q3 (2023-09-30) $10,934,281 2.38% 657,899 $20.40
3 2023 - Q2 (2023-06-30) $10,682,057 2.74% 571,233 $19.47
4 2023 - Q1 (2023-03-31) $7,943,715 6.96% 432,900 $25.28
5 2022 - Q4 (2022-12-31) $8,571,420 8.01% 432,900 $20.01
6 2022 - Q3 (2022-09-30) $10,416,000 9.66% 432,900 $23.64
7 2022 - Q2 (2022-06-30) $7,900,000 6.71% 432,900 $16.66
8 2022 - Q1 (2022-03-31) $9,519,000 5.53% 432,900 $23.61
9 2021 - Q4 (2021-12-31) $15,900,000 9.03% 432,900 $33.41
10 2021 - Q3 (2021-09-30) $19,722,000 9.58% 635,177 $33.05
11 2021 - Q2 (2021-06-30) $23,391,000 7.59% 735,801 $23.36
12 2021 - Q1 (2021-03-31) $16,335,000 5.46% 735,801 $20.61
13 2020 - Q4 (2020-12-31) $14,532,000 3.07% 735,801 $27.18

The displayed share prices are average quarterly stock market prices.